249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency

A. Zuckermann; A. Keogh; M.G. Crespo-Leiro; D. Mancini; F. Gonzalez-Vilchez; L. Almenar; S. Brozena; H. Eisen; S. See Tai; S. Kashwaha

doi:10.1016/j.healun.2009.11.260

249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2009.11.260 ◽

2010 ◽

Vol 29 (2) ◽

pp. S85-S85

Author(s):

A. Zuckermann ◽

A. Keogh ◽

M.G. Crespo-Leiro ◽

D. Mancini ◽

F. Gonzalez-Vilchez ◽

...

Keyword(s):

Renal Insufficiency ◽

Calcineurin Inhibitor ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Continued Use ◽

Moderate Renal Insufficiency

Download Full-text

A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2003.11.196 ◽

2004 ◽

Vol 23 (2) ◽

pp. S107 ◽

Cited By ~ 1

Author(s):

M Cantarovich ◽

H Ross ◽

J Arizon ◽

J Orus ◽

L Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2-hr monitoring of Neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction: 6-month outcomes

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2004.11.085 ◽

2005 ◽

Vol 24 (2) ◽

pp. S62 ◽

Cited By ~ 1

Author(s):

H. Ross ◽

M. Cantarovich ◽

J. Arizon ◽

J. Orus ◽

L. Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

A 12-MONTH, MULTICENTER, RANDOMIZED, ADAPTIVE DESIGN, OPEN-LABEL STUDY TO EVALUATE THE BENEFIT OF C2 HOUR MONITORING OF NEORAL ON SAFETY AND EFFICACY OUTCOMES IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS RECEIVING BASILIXIMAB INDUCTION

Transplantation Journal ◽

10.1097/00007890-200407271-01123 ◽

2004 ◽

Vol 78 ◽

pp. 420

Author(s):

M Cantarovich ◽

H Ross ◽

J Arizon ◽

M A. Gomez ◽

L Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

56 Safety and Efficacy of Conversion to Sirolimus vs Continued Calcineurin Inhibitor Use in Cardiac Transplant Recipients with Renal Insufficiency

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2011.01.063 ◽

2011 ◽

Vol 30 (4) ◽

pp. S26

Author(s):

A. Zuckermann ◽

A. Keogh ◽

M.G. Crespo-Leiro ◽

D. Mancini ◽

F. Gonzalez Vilchez ◽

...

Keyword(s):

Renal Insufficiency ◽

Calcineurin Inhibitor ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Safety And Efficacy

Download Full-text

EFFECT OF CONVERSION FROM CALCINEURIN INHIBITORS (CNIS) TO SIROLIMUS ON RENAL FUNCTION IN CARDIAC TRANSPLANT RECIPIENTS WITH MILD TO MODERATE RENAL INSUFFICIENCY: INTERIM SAFETY AND EFFICACY RESULTS

Transplantation Journal ◽

10.1097/00007890-201007272-00236 ◽

2010 ◽

Vol 90 ◽

pp. 122

Author(s):

M. G. Crespo-Leiro ◽

A. Zuckermann ◽

A. Keogh ◽

D. Mancini ◽

F. González-Vilchez ◽

...

Keyword(s):

Renal Function ◽

Renal Insufficiency ◽

Calcineurin Inhibitors ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Safety And Efficacy ◽

Moderate Renal Insufficiency

Download Full-text

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Case Medical Research ◽

10.31525/ct1-nct03977792 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Labialis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Recurrent Herpes ◽

Cold Sores

Download Full-text

An Open-label Study of the Safety and Efficacy of Tag-7 Gene-modified Tumor Cell-based Vaccine in Patients With Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

Case Medical Research ◽

10.31525/ct1-nct04180774 ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Melanoma ◽

Tumor Cell ◽

Renal Cell ◽

Cell Cancer ◽

Locally Advanced ◽

Metastatic Malignant Melanoma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725336183.793540487 ◽

2017 ◽

Author(s):

Lori Ann Birder

Keyword(s):

Overactive Bladder ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Post Marketing

Download Full-text

Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

Journal of Bone and Mineral Research ◽

10.1002/jbmr.4274 ◽

2021 ◽

Author(s):

Sofia Ish‐Shalom ◽

Yoseph Caraco ◽

Nariman Saba Khazen ◽

Michal Gershinsky ◽

Auryan Szalat ◽

...

Keyword(s):

Parathyroid Hormone ◽

Human Parathyroid Hormone ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Cited By ~ 42

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text